9-ING-41, CAS [[1034895-42-5]]

Produktübersicht

• Artikelname: 9-ING-41, CAS [[1034895-42-5]]
• Artikelnummer: MCE-HY-113914
• Hersteller Artikelnummer: HY-113914
• Alternativnummer: MCE-HY-113914-5MG,MCE-HY-113914-10MMX1ML,MCE-HY-113914-50MG,MCE-HY-113914-10MG,MCE-HY-113914-100MG,MCE-HY-113914-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: Elraglusib

Produktbeschreibung

9-ING-41 (Elraglusib) is a maleimide-based ATP-competitive and selective glycogen synthase kinase-3beta (GSK-3beta) inhibitor with an IC50 of 0.71 µM. 9-ING-41 significantly leads to cell cycle arrest, autophagy and apoptosis in cancer cells. 9-ING-41 has anticancer activity and has the potential for enhancing the antitumor effects of chemotherapeutic agents[1][2][3][4].

Produkteigenschaften

• Molekulargewicht: 404.35
• Reinheit: 99.13
• CAS Nummer: [1034895-42-5]
• Formel: C22H13FN2O5
• Target-Kategorie: Apoptosis,Autophagy,GSK-3

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound